Chargement en cours...
Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older
Finding safe and effective treatments for chronic hepatitis C virus (HCV) infection in the elderly is of clinical interest given the comorbidities and associated polypharmacy in this population. However, the number of patients older than age 65 years enrolled into clinical trials of anti-HCV medicat...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314565/ https://ncbi.nlm.nih.gov/pubmed/30601818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0208506 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|